Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Oct 11;18(1):513.
doi: 10.1186/s12879-018-3421-1.

Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals

Kaidi Telling  1 , Mailis Laht  2 , Age Brauer  3 , Maido Remm  3 , Veljo Kisand  2 , Matti Maimets  4 , Tanel Tenson  2 , Irja Lutsar  5
Affiliations
Clinical Trial

Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals

Kaidi Telling et al. BMC Infect Dis. .

Abstract

Background: We aimed to identify the main spreading clones, describe the resistance mechanisms associated with carbapenem- and/or multidrug-resistant P. aeruginosa and characterize patients at risk of acquiring these strains in Estonian hospitals.

Methods: Ninety-two non-duplicated carbapenem- and/or multidrug-resistant P. aeruginosa strains were collected between 27th March 2012 and 30th April 2013. Clinical data of the patients was obtained retrospectively from the medical charts. Clonal relationships of the strains were determined by whole genome sequencing and analyzed by multi-locus sequence typing. The presence of resistance genes and beta-lactamases and their origin was determined. Combined-disk method and PCR was used to evaluate carbapenemase and metallo-beta-lactamase production.

Results: Forty-three strains were carbapenem-resistant, 11 were multidrug-resistant and 38 were both carbapenem- and multidrug-resistant. Most strains (54%) were isolated from respiratory secretions and caused an infection (74%). Over half of the patients (57%) were ≥ 65 years old and 85% had ≥1 co-morbidity; 96% had contacts with healthcare and/or had received antimicrobial treatment in the previous 90 days. Clinically relevant beta-lactamases (OXA-101, OXA-2 and GES-5) were found in 12% of strains, 27% of which were located in plasmids. No Ambler class B beta-lactamases were detected. Aminoglycoside modifying enzymes were found in 15% of the strains. OprD was defective in 13% of the strains (all with CR phenotype); carbapenem resistance triggering mutations (F170 L, W277X, S403P) were present in 29% of the strains. Ciprofloxacin resistance correlated well with mutations in topoisomerase genes gyrA (T83I, D87N) and parC (S87 L). Almost all strains (97%) with these mutations showed ciprofloxacin-resistant phenotype. Multi-locus sequence type analysis indicated high diversity at the strain level - 36 different sequence types being detected. Two sequence types (ST108 (n = 23) and ST260 (n = 18)) predominated. Whereas ST108 was associated with localized spread in one hospital and mostly carbapenem-resistant phenotype, ST260 strains occurred in all hospitals, mostly with multi-resistant phenotype and carried different resistance genotype/machinery.

Conclusions: Diverse spread of local rather than international P. aeruginosa strains harboring multiple chromosomal mutations, but not plasmid-mediated Ambler class B beta-lactamases, were found in Estonian hospitals.

Trial registration: This trial was registered retrospectively in ClinicalTrials.gov ( NCT03343119 ).

Keywords: Beta-lactamases; Carbapenem resistance; Outbreak; WGS (whole-genome sequencing).

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The study protocol was approved with a waiver of informed consent by the Ethics Committee of the University of Tartu.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Analysis of 92 sequenced carbapenem or/and multiresistant P.aeruginosa genomes. A maximum-likelihood tree and MLST analysis, presence of beta-lactamases and their location (either in plasmid or chromosome) and aminoglycoside modifying enzymes, selected mutations in quinolone resistance-determining region (QRDR) and OprD. Tested antimicrobial susceptibilities are presented as follows: green color – susceptible; orange color – intermediate and red – resistant strain. CARBA represents coordinated results of phenotypic testing of class B beta-lactamases by combined-disk method and PCR where tested strains are marked with a dark blue color
See this image and copyright information in PMC

References

    1. Silby MW, Winstanley C, Godfrey SA, Levy SB, Jackson RW. Pseudomonas genomes: diverse and adaptable. FEMS Microbiol Rev. 2011;35(4):652–680. doi: 10.1111/j.1574-6976.2011.00269.x. - DOI - PubMed
    1. Estepa V, Rojo-Bezares B, Torres C, Saenz Y. Faecal carriage of Pseudomonas aeruginosa in healthy humans: antimicrobial susceptibility and global genetic lineages. FEMS Microbiol Ecol. 2014;89(1):15–19. doi: 10.1111/1574-6941.12301. - DOI - PubMed
    1. Ciofu O, Tolker-Nielsen T, Jensen PO, Wang H, Hoiby N. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. Adv Drug Deliv Rev. 2015;85:7–23. doi: 10.1016/j.addr.2014.11.017. - DOI - PubMed
    1. Wolf SE, Phelan HA, Arnoldo BD. The year in burns 2013. Burns. 2014;40(8):1421–1432. doi: 10.1016/j.burns.2014.10.026. - DOI - PubMed
    1. Gomez-Zorrilla S, Camoez M, Tubau F, Periche E, Canizares R, Dominguez MA, Ariza J, Pena C. Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patients. Antimicrob Agents Chemother. 2014;58(10):5863–5870. doi: 10.1128/AAC.03419-14. - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data